Has Ali Nairizi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $290,857 in general payments to Ali Nairizi, MD across 1,150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ali Nairizi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ali Nairizi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ali Nairizi, MD

Interventional Pain Medicine · Reno, NVNPI 1700032273

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Nevro Corp. at 35.0% of the total. Among interventional pain medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$290,857in general payments, 2019–2025

Across 1,150 payments — averaging $252.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$102K
Si-bone, Inc.$42K
Saluda Medical Americas, Inc.$31K
Vertex$27K
Aurora Spine, Inc.$21K
Surgentec$12K
plus $56K from 54 others

$461,982in research payments, 2019–2025

Across 88 payments — averaging $5249.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Nevro Corp.$382K
Saluda Medical Americas, Inc.$48K
Mesoblast, Inc.$26K
Globus Medical$4K
Abbott$2K
Biotronik Inc.$731

What the payments were for

Consulting fees$135,07246%
Speaking & faculty fees$82,74528%
Travel & lodging$30,50910%
Food & beverage$38,11913%
Education$1,2380%
Entertainment$3,1751%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	296	$101,884
Si-bone, Inc.	101	$41,552
Saluda Medical Americas, Inc.	97	$31,374
Vertex	32	$26,850
Aurora Spine, Inc.	12	$21,125
Surgentec	6	$12,016
Boston Scientific	132	$11,898
Flowonix Medical Incorporated	2	$10,494
Tersera Therapeutics LLC	35	$7,639
Foundation Fusion Solutions, LLC	25	$6,035
Medtronic(2 entities)	56	$2,942
Pacira Pharmaceuticals Incorporated	6	$1,947
Abbott	42	$1,884
Globus Medical	18	$1,828
Stryker	16	$1,694
Vertos Medical, Inc.	6	$1,550
AbbVie(2 entities)	54	$1,044
Spinefrontier, Inc.	1	$560
Neuronetics, Inc.	10	$553
Relievant Medsystems, Inc.	10	$468
Pfizer	22	$408
Nalu Medical, Inc.	7	$392
Amgen(2 entities)	18	$374
Curonix LLC	6	$372
Collegium Pharmaceutical, Inc.	19	$292
Merz North America, Inc.	3	$286
Spinal Simplicity, LLC	2	$257
Merz Pharmaceuticals, LLC	8	$254
Teva Pharmaceuticals USA, Inc.	18	$235
Brixton Biosciences, Inc.	1	$193
Stimwave Technologies Incorporated	3	$188
Corelink, LLC	2	$169
Biotronik NRO, Inc.	2	$166
Vanda Pharmaceuticals Inc.	6	$157
Bioventus LLC	4	$138
Vertiflex, Inc.	6	$129
Orthofundamentals, LLC	1	$127
Axonics, Inc.	2	$114
Painteq LLC	2	$102
Biohaven Pharmaceutical Holding Company Ltd.	6	$101
Novartis	6	$89
Biodelivery Sciences International, Inc.	5	$85
Pacira Therapeutics, Inc.	4	$78
Sanofi-aventis U.S. LLC	2	$69
Biohaven Pharmaceuticals, Inc.	4	$67
Daiichi Sankyo Inc.	3	$62
Redhill Biopharma Inc.	3	$61
Forte Bio-pharma LLC	2	$57
Lilly USA, LLC	4	$56
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$46
Saol Therapeutics Inc.	1	$45
Hydrocision, Inc.	1	$40
GRT US Holding, Inc.	2	$39
Arbor Pharmaceuticals, Inc.	2	$37
Johnson & Johnson	2	$35
SPR Therapeutics, Inc	2	$30
Ipsen Biopharmaceuticals, Inc	1	$25
Piramal Critical Care	1	$23
Zimvie Inc.	1	$22
Almatica Pharma LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza Spinal Cord Stimulation System$45,512
IFUSE IMPLANT SYSTEM$38,466
Omnia$30,628
Evoke$26,847
JOURNAVX$26,388
Senza$22,030
ZIP$21,125
Prometra II$10,494
ION Facet Screw$9,861
WAVEWRITER ALPHA$7,100
PRIALT$7,050
Evoke SCS$2,630
3D GraftRasp System$2,059
EXPAREL$1,880
GENERAL PAIN MANAGEMENT$1,701
mild Device Kit$1,422
IVS - VERTEBRAL AUGMENTATION PRODUCTS$993
INTELLIS ADAPTIVESTIM$901
Intracept$790
InSpan$560

How this compares

$290,857 in reported general payments places this provider in the 95th percentile of 32 interventional pain medicine providers in Nevada.

See all interventional pain medicine providers in Nevada →

Medicare billing

Part B allowed, 2024

$769,759

Medicare patients

405

Services billed

14,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	53	$1,450
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	27	$762
Oxycodone Hcl	56	$728
Pregabalin	26	$504
Cephalexin	67	$388
Gabapentin	32	$361
Morphine Sulfate ErMorphine Sulfate	13	$298
Tizanidine Hcl	15	$194
Clindamycin Hcl	21	$165
Methocarbamol	12	$79
Tramadol Hcl	11	$18

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Reno

Steven BermanReno$25K
Benjamin GillReno$22K
Christopher WoolleyReno$18K
Adam AntflickLas Vegas$26K
Stephen GephardtLas Vegas$14K
Jeremy LipshutzLas Vegas$13K
Denys GoloshchapovLas Vegas$11K
Jeffrey KatzNorth Las Vegas$7K
Edson ErkulvrawatrLas Vegas$6K
Alafuro OrueneLas Vegas$6K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →